Hematologic Cancers

Keeping Up to Date on New Multiple Myeloma Drugs
Leslie Lauersdorf addresses the challenges associated with staying abreast of the side effects, management, and sequencing for new multiple myeloma treatments. Read More ›

Survivorship Care and Multiple Myeloma
As patients with multiple myeloma are now living longer, survivorship care is becoming more crucial. Read More ›

How Janssen CarePath Helps Patients
Beth Faiman identifies how the Janssen CarePath program can financially help anyone who is diagnosed with multiple myeloma and requires daratumumab. Read More ›

Concerns Over New Multiple Myeloma Therapies
Beth Faiman expresses her main concerns regarding new treatments being studied to treat multiple myeloma. Read More ›

Self-Managing Side Effects
Beth Faiman discusses why it's important to communicate with and educate patients so that they can better manage their symptoms before they become more severe. Read More ›

The Challenge of Managing Treatment-Related Toxicites
Beth Faiman explains how she identfies side effects that her patients are experiencing in order to open the lines of communication to better address other issues the patient may not be aware of. Read More ›

Unmet Needs in Patients with Myeloma
Patients with newly diagnosed multiple myeloma have different needs than pateints relapsed/refractory disease, and Beth Faiman addresses what some of these needs are. Read More ›

What Do Patients Ask About Daratumumab?
Beth Faiman gets questions from her patients about daratumumab on an almost daily basis. Find out what their most asked questions are. Read More ›

Starting a Patient on Daratumumab

Perceptions of Daratumumab Therapy

Page 3 of 10


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: